These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 21520073)
1. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells. Mlejnek P; Dolezel P; Kosztyu P J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073 [TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis by A3 adenosine receptor agonist N-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide in human leukaemia cells: a possible involvement of intracellular mechanism. Mlejnek P; Dolezel P Acta Physiol (Oxf); 2010 Jun; 199(2):171-9. PubMed ID: 20121715 [TBL] [Abstract][Full Text] [Related]
3. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling. Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967 [TBL] [Abstract][Full Text] [Related]
4. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations. Mlejnek P; Dolezel P; Frydrych I J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730 [TBL] [Abstract][Full Text] [Related]
5. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells. Morello S; Sorrentino R; Porta A; Forte G; Popolo A; Petrella A; Pinto A J Cell Physiol; 2009 Nov; 221(2):378-86. PubMed ID: 19562684 [TBL] [Abstract][Full Text] [Related]
6. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor. Ge ZD; Peart JN; Kreckler LM; Wan TC; Jacobson MA; Gross GJ; Auchampach JA J Pharmacol Exp Ther; 2006 Dec; 319(3):1200-10. PubMed ID: 16985166 [TBL] [Abstract][Full Text] [Related]
7. Adenosine A(3) receptor-induced proliferation of primary human coronary smooth muscle cells involving the induction of early growth response genes. Hinze AV; Mayer P; Harst A; von Kügelgen I J Mol Cell Cardiol; 2012 Nov; 53(5):639-45. PubMed ID: 22906537 [TBL] [Abstract][Full Text] [Related]
8. A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells. Lee EJ; Min HY; Chung HJ; Park EJ; Shin DH; Jeong LS; Lee SK Biochem Pharmacol; 2005 Sep; 70(6):918-24. PubMed ID: 16051194 [TBL] [Abstract][Full Text] [Related]
9. Stimulation of ANP secretion by 2-Cl-IB-MECA through A(3) receptor and CaMKII. Yuan K; Bai GY; Park WH; Kim SZ; Kim SH Peptides; 2008 Dec; 29(12):2216-24. PubMed ID: 18838091 [TBL] [Abstract][Full Text] [Related]
10. Thio-Cl-IB-MECA, a novel A₃ adenosine receptor agonist, suppresses angiogenesis by regulating PI3K/AKT/mTOR and ERK signaling in endothelial cells. Kim GD; Oh J; Jeong LS; Lee SK Biochem Biophys Res Commun; 2013 Jul; 437(1):79-86. PubMed ID: 23791876 [TBL] [Abstract][Full Text] [Related]
11. Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation. Morello S; Petrella A; Festa M; Popolo A; Monaco M; Vuttariello E; Chiappetta G; Parente L; Pinto A Cancer Biol Ther; 2008 Feb; 7(2):278-84. PubMed ID: 18059189 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of cell proliferation through cell cycle arrest and apoptosis by thio-Cl-IB-MECA, a novel A3 adenosine receptor agonist, in human lung cancer cells. Kim SJ; Min HY; Chung HJ; Park EJ; Hong JY; Kang YJ; Shin DH; Jeong LS; Lee SK Cancer Lett; 2008 Jun; 264(2):309-15. PubMed ID: 18321638 [TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis in rat cardiocytes by A3 adenosine receptor activation and its suppression by isoproterenol. Shneyvays V; Jacobson KA; Li AH; Nawrath H; Zinman T; Isaac A; Shainberg A Exp Cell Res; 2000 May; 257(1):111-26. PubMed ID: 10854059 [TBL] [Abstract][Full Text] [Related]
14. An adenosine analogue, IB-MECA, down-regulates estrogen receptor alpha and suppresses human breast cancer cell proliferation. Lu J; Pierron A; Ravid K Cancer Res; 2003 Oct; 63(19):6413-23. PubMed ID: 14559831 [TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis in cardiac myocytes by an A3 adenosine receptor agonist. Shneyvays V; Nawrath H; Jacobson KA; Shainberg A Exp Cell Res; 1998 Sep; 243(2):383-97. PubMed ID: 9743598 [TBL] [Abstract][Full Text] [Related]
16. Attenuation of Sunitinib-induced cardiotoxicity through the A3 adenosine receptor activation. Sandhu H; Cooper S; Hussain A; Mee C; Maddock H Eur J Pharmacol; 2017 Nov; 814():95-105. PubMed ID: 28811127 [TBL] [Abstract][Full Text] [Related]
17. The adenosine A3 receptor agonist Cl-IB-MECA induces cell death through Ca²⁺/ROS-dependent down regulation of ERK and Akt in A172 human glioma cells. Kim TH; Kim YK; Woo JS Neurochem Res; 2012 Dec; 37(12):2667-77. PubMed ID: 22878643 [TBL] [Abstract][Full Text] [Related]
18. Activation of adenosine A3 receptors reduces ischemic brain injury in rodents. Chen GJ; Harvey BK; Shen H; Chou J; Victor A; Wang Y J Neurosci Res; 2006 Dec; 84(8):1848-55. PubMed ID: 17016854 [TBL] [Abstract][Full Text] [Related]
19. A role for histamine in cytokine modulation by the adenosine A(3) receptor agonist, 2-Cl-IB-MECA. Smith SR; Denhardt G; Terminelli C Eur J Pharmacol; 2002 Dec; 457(1):57-69. PubMed ID: 12460644 [TBL] [Abstract][Full Text] [Related]
20. An adenosine analog (IB-MECA) inhibits anchorage-dependent cell growth of various human breast cancer cell lines. Panjehpour M; Karami-Tehrani F Int J Biochem Cell Biol; 2004 Aug; 36(8):1502-9. PubMed ID: 15147729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]